November 4, 2014 05:12 PM EST 0 comments

Increased Access to Innovative Prescription Medications Helps Slow Overall Medicare Spending

A recent report by Peter J. Pitts, president and co-founder of the Center for Medicine in the Public Interest (CMPI), suggests that increased access to innovative prescription medication made possible by the implementation of Medicare Part D is actually helping to reduce overall Medicare spending.

Read More

October 24, 2014 03:23 PM EDT 0 comments

Inaugural Closing the Gap Now Symposium to Feature Marathoner and Multiple Myeloma Survivor Don Wright

Closing the Gap Now, a new symposium dedicated to speeding access to innovative, life-saving therapies, has added marathon runner and multiple myeloma survivor Don Wright to its roster of speakers and panelists.

Read More

October 13, 2014 12:24 PM EDT 0 comments

Runner and Multiple Myeloma Survivor Don Wright Completes 84th Marathon!

This past weekend, multiple myeloma survivor Don Wright completed the Ottawa Fall Colours Marathon – his 84th! Thanks to innovative cancer treatments, Don has been able to run marathons in all 50 states, spending precious time with his family and friends and raising awareness of the value of new cancer therapies.

Read More

October 7, 2014 11:23 AM EDT 0 comments

New Study Suggests Innovative Therapies Lower Total Cancer Care Costs

Not only do innovative cancer therapies save lives – they save money! A new study in the Journal of Oncology Practice suggests that new treatments lower overall cancer care costs by shortening hospital stays and reducing reliance on radiation therapy.

Read More

September 10, 2014 06:58 PM EDT 0 comments

Century Cures Initiative Convenes Congressional Roundtable to Discuss Accelerating the Pace of 21st Cures

Members of Congress were further alerted to many of the issues preventing efficient clinical trials and patient access to innovative medication during a roundtable discussion convened on Wednesday, September 10, 2014 by the House Committee on Energy and Commerce as part of the non-partisan 21st Century Cures initiative. While the conversation was not limited to cancer medication, the event raised several key points about the ongoing struggle to streamline the clinical trial process.

Read More